Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients.
Andra CA, Rambe AS, Hasan R, Sembiring R, Firman D, Eyanoer PC, Mukhtar Z, Sungkar T, Rusda M, Amin MM.
Andra CA, et al.
Narra J. 2023 Dec;3(3):e409. doi: 10.52225/narra.v3i3.409. Epub 2023 Nov 12.
Narra J. 2023.
PMID: 38455605
Free PMC article.
A case-control study using consecutive sampling was conducted among CAD patients at H. Adam Malik General Hospital and Murni Teguh Memorial Hospital, Medan, Indonesia. A total of 200 CAD patients were divided into two groups based on the SYNTAX score: control (score 22, n= …
A case-control study using consecutive sampling was conducted among CAD patients at H. Adam Malik General Hospital and Murni Teguh Me …